CLINICAL & HORMONAL EFFECTS OF GHRP-2, GHRH AND GHRP-2+GHRH IN ELDERLY SUBJECTS

临床

• 批准号: 7376235
• 负责人: CYRIL Y BOWERS
• 金额: $ 1.67万
• 依托单位: TULANE UNIVERSITY OF LOUISIANA
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7376235
• 关键词: CLINICAL; HORMONAL; EFFECTS; GHRP; GHRH

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of this study is to determine the effect of Growth Hormone Releasing Peptide-2 (GHRP-2) alone and in combination with Growth Hormone Releasing Hormone (GHRH) in order to study the pathophysiology of decreased Growth Hormone (GH) secretion and to determine abnormal from normal GH secretion in subjects ages 40-80 years.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。所列机构为中心机构，不一定为研究者机构。本研究的主要目的是确定生长激素释放肽-2（GHRP-2）单独使用和与生长激素释放激素（GHRH）联合使用的效果，以研究生长激素（GH）分泌减少的病理生理学，并确定40-80岁受试者的正常GH分泌异常。